Materials 9-Fluorenylmethyloxycarbonyl (Fmoc) ester of amino acids, an amide polyethyleneglycole-polystyrene (PEG-PS) resin, and other reagents to be used for peptide synthesis, were purchased from Kokusan Chemical Works, Ltd. (Tokyo, Japan) and Nihon Perseptive, Ltd. (Tokyo, Japan). Dipalmitoylphosphatidylcholine (DPPC), dilauroylphosphatidylglycerol (C12 : 0) (DLPG), dimyristoylphosphatidylglycerol (C14 : 0) (DMPG), dipalmitoylphosphatidylglycerol (C16 : 0) (DPPG), distearoylphosphatidylglycerol (C18 : 0) (DSPG), palmitoyl-oleoyl-phosphatidylglycerol (C16 : 0, 18 : 1) (POPG) and egg-phosphatidylglycerol (E-PG; sodium salt, prepared from egg yolk phosphatidylcholine), were obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.). Palmitic acid (PA) was from Tokyo Kasei Kogyo Co., Ltd. (Tokyo, Japan). Surfacten ® (Surfactant TA) was a modified bovine lung surfactant containing a small percentage of proteins and about 95% lipids, and was supplied by Mitsubishi Pharma. Co., Ltd. (Tokyo, Japan). All other chemicals were of reagent grade.
Synthesis and Purification of SP-CL16(6-28) Peptide synthesis was carried out by the stepwise solid-phase method with a peptide synthesizer (Pepsynthesizer ® model 9050 plus, Nihon PerSeptive), as described previously. 9) The purification of cleaved peptide has been described in detail. 9) Briefly, the peptide was purified by centrifugal partition chromatography (CPC) performed on a model LLN-B (Sanki Engineering, Tokyo, Japan) machine equipped with a 2056-cartridge column, and developed with the n-hexane/ CH 3 OH/H 2 O/trifluoroacetic acid (TFA) solvent system by the descending method. Purified peptide was stored at Ϫ20°C.
Analysis of Synthetic Peptide by Mass Spectrometry
The peptide was identified using an electrospray-ionization mass spectrometry analyzer model Quatro LC (JASCO Inter-national, Tokyo, Japan).
Quantitative Amino Acid Analysis The composition of the purified peptide was determined as described previously.
9)
Preparation of Synthetic Lung Surfactant (SLS) SLS containing the peptide was prepared in the following manner 7) : SP-CL16(6-28) dissolved in a small volume of TFA was mixed with a ternary lipid mixture of DPPC/phosphatidylglycerol (PG)/PA (75 : 25 : 10, w/w) in a CHCl 3 / CH 3 OH (2 : 1, v/v) solution to produce a peptide-lipid mixture containing 2% SP-CL16(6-28) on a weight/weight basis relative to the phospholipids. The peptide-lipid mixture was suspended in 10% ethanol, incubated at 40-45°C for 15 min, and then lyophilized to obtain a white powder. This admixture was dispersed in saline by sonication for 1 min in ice-cold water and stored in nitrogen at Ϫ20°C. The final concentration of phospholipids was 10 mg/ml. Surfactant-TA was also dispersed in saline at a phospholipid concentration of 25 mg/ml.
Measurement of Surface Properties with a Langmuir-Wilhelmy Surface Balance Surface spreading and dynamic surface activities were measured with a modified Wilhelmy surface balance (Kyowa, Tokyo, Japan) at 37Ϯ 1°C, as described previously. 7) Data of the fourth surface tension-area diagram is shown in the tables. The surface area at 10 mN/m obtained from the diagram was expressed as a percentage of the total area.
Measurement of Surface Activities with a Pulsating Bubble Surfactometer Surface tension was measured during dynamic compression using a pulsating bubble surfactometer (Electronetics Co., NY, U.S.A.), as described. 10) Briefly, a bubble of ambient air drawn through a small tube is formed in a chamber containing a surfactant suspension. This bubble pulsates at 37Ϯ1°C at a rate of 20 cycles per min between fixed radius (0.4-0.55 mm), resulting in a 50% change in surface area. The pressure across the bubble is measured by a pressure transducer, and the surface tension can be calculated from the Law of Laplace: Pϭ2g/r. All surfactant samples assayed on the bubble machine were made up in buffers containing saline. These SLSs were assayed at a concentration of 2.5 mg/ml.
Measurement of Lung Pressure-Volume Characteristics of Fetal Rabbits
The measurement of lung pressurevolume characteristics in premature rabbit fetus (gestational age of 27 d) was carried out according to the method of Enhorning and Robertson 11) with several modifications. A surfactant suspension containing 50 mg of phospholipid per kg body weight was instilled into the trachea of the fetus.
Data Analyses Statistical analyses were performed using Student's unpaired t-test. All data were depicted as the meanϮS.D. p values of less than 0.01 were considered to indicate a statistically significant difference.
RESULTS

Surface Activity of SLS in a Langmuir-Wilhelmy Surface Balance
The surface activity of the SLS improved the in vitro surface activity of a ternary lipid mixture composed of DPPC/PG/PA (75 : 25 : 10, w/w) in a Langmuir-Wilhelmy surface balance. The levels of surface activity are shown in Table 1 . Table 1 summarizes the spreading kinetics and dynamic compression-expression properties of SP-CL16(6-28) after association with the lipid mixture of DPPC/PG/PA.
DPPC/E-PG/PA plus SP-CL16(6-28) (EPG-SLS) markedly increased the spreading rate, and the surface tension reached 26.8 mN/m at 120 s. After 3 min of spreading, surface tension-area diagrams of the surfactant film during dynamic cycling were made with phospholipids at an internal concentration of 1.5 mg/cm 2 . More than 60% of the surface area (compression) had a tension of 10 mN/m, with a minimum surface tension (g min ) and maximum surface tension (g max ) of 2.3 mN/m and 28.9 mN/m, respectively. DPPC/POPG/PA plus SP-CL16(6-28) (POPG-SLS) significantly increased the spreading rates, and the surface tension reached 28.3 mN/m at 120 s. The g min and g max was 1.7 mN/m and 28.6 mN/m, respectively. The value of compression reached 80.5%. In contrast, DLPG DPPC/DLPG/PA plus SP-CL16(6-28) (DLPG-SLS) exhibited a g max of 1304 Vol. 25, No. 10 
Lung Pressure-Volume Characteristics in the Model
Using Premature Fetal Rabbits Lung pressure-volume characteristics of prematurely delivered rabbit fetuses (gestational age of 27 d) after tracheal instillation of DPPC/E-PG/PA, DPPC/POPG/PA, EPG-SLS and POPG-SLS are shown in Fig. 1B . The positive control of Surfacten-TA is shown in Fig. 1A . The lipid mixture alone exhibited no noticeable effect on the LV characteristics of the fetuses. The LV30 of saline was 10.7 ml/kg body, and the LV5, 2.8 ml/kg body. The LV30 and LV5 of a due fetus were 61.5, and 44.8 ml/kg body, respectively. The values for surfactant-TA were 74.7 and 48.0 ml/kg body, respectively (Fig. 1A) .
POPG-SLS significantly improved the characteristics of the fetuses with an LV5 of 44.8 ml/kg body and LV30 of 76.2 ml/kg body, which was comparable to that of Surfacten-TA (Fig. 1B) . The LV30 and LV5 of DPPC/PG/PA were 27.0 and 15.8 ml/kg body, respectively. The significant improvement in respiratory function was not accepted.
DISCUSSION
This research aims at the development of a synthetic surfactant formulation effective in the clinical target, in which replacement of the natural surfactant of the bovine is possible. Considering the utilization of this formulation, it is very important to research consider the influence that the chemical composition has on the surface activity. We previously synthesized human SP-C analogues, and found the SP-CL16(6-28) to be comparable in surface activity with surfactant-TA, a modified surfactant. However, there has been no previous characterization of a synthetic surfactant using such a series of RDS models.
The purpose of this study was to characterize the surface activity of SLS with various PGs. We attempted an in vitro assay (WSB and PBS), and examined biological properties using the IRDS model. In WSB, Tanaka et al., 12, 13) considered the influence of the surface activity exerted on the chemical components of a natural surfactant. The criteria were as follows: surface spreading was less than 35 mN/m after the sample was allowed to stand for 120 s. g max was less than 35 mN/m, and compression was more than 60%. Various PG-containing SLS samples were demonstrated to be highly active in reducing surface spreading and respreading of a lipid film during dynamic cycles ( Table 1) . The only SLS sample that did not satisfy the criteria was DLPG-SLS.
PBS is now the standard procedure for investigating the activity of a lung surfactant in vitro. PBS, unlike WSB, is similar to the human physiological respiratory mechanism, since the compression period on the front face of the liquid phase of physiological saline was as short as 20 cycles/min, and the surface pressure decreased by 50%. It likens the foam created in the surfactant sample with the alveolus, and carries out the throb at the same velocity as the ventilation rate. This suggests that the g min of the sample is equivalent to the surface tension of the alveolar of a respiration term, and it is speculated that the alveolus cannot maintain respiratory function when the value exceeds 10 mN/m. 14, 15) We have established g min and adsorption to be the important parameters in the lung. The criteria were as follows: g min is less than 10 mN/m at a pulsating time after 5 min, and adsorption is less than 35 mN/m after the sample is allowed to stand for 10 s.
The level of g min DLPG-SLS was 18.4 mN/m, and did not satisfy the criteria. All surfactants other than DLPG-SLS satisfied the criteria. However, DSPG-SLS had a g max value of 43.1 mN/m, high even compared with surfactant-TA. DPPG also had a g max value of 44.8 mN/m. Collectively, POPG-SLS and EPG-SLS showed outstanding surface activity.
The surface activity of DLPG-SLS was weak. There are few carbons in the acyl group of DLPG compared with other PG. Therefore, in a state of association, the lipid molecule is considered to have condensed more and to have bonded together. Since it cannot effectively penetrate the bimolecular lipid membrane of such a DPPC/DLPG/PA mixture, 16) SP-CL16(6-28) had weak surface activity. We chose POPG-SLS and EPG-SLS which had excellent surface activity both in the primary screening of WSB and in the secondary screening of PBS, and estimated the improvement in respiratory function with the IRDS model in vivo. We set up the criteria for respiration of a premature fetus by a synthetic surfactant in the IRDS model that is equivalent to LV5 of a fullterm fetus.
POPG-SLS and EPG-SLS remarkably improved the LV activity of a premature fetus. Significant improvement, in which the level was equal to the activity of a full-term fetus, was observed. Even if one compared the activity with Surfactant-TA, an equivalent improvement in respiratory function was achieved. On the other hand, the activity of DPPC/PG/PA was not sufficient, although it improved the LV30 and LV5 of a premature fetus as compared with saline.
In this examination, even if SP-CL16(6-28) used PG, it had surface activity equal to Surfactant-TA, and it was clear that there was little influence on the surface activity by any PG. As compared with EPG-SLS using E-PG of egg origin, which has mixed components, control of the manufacturing process is easy for POPG-SLS using POPG, which is a single component. That is, it seems that SLS was useful when using the RDS treatment agent of the synthetic surfactant.
